Research Article

Combined Treatment of Adipose Derived-Mesenchymal Stem Cells and Pregabalin Is Superior to Monotherapy for the Treatment of Neuropathic Pain in Rats

Figure 4

Nerve conduction velocity on day 21 posttreatment. The injured group showed a significant decrease in nerve conduction velocity (cm/seconds) compared to the sham group. All treated groups showed an increase in the nerve conduction velocity ( vs. sham, #injured, @adipose tissue-derived mesenchymal stem cells (ADMSCs), ^pregabalin, or $combined). The combined treatment was not significantly different than ADMSCs or pregabalin alone ().